AbCellera Biologics Inc.

AbCellera Biologics Inc. (AbCellera) (https://www.abcellera.com/) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

• Cramer's lightning round: I want to buy more Marvell Technology (US.MRVLN) - 17 mai 2022
• AbCellera Biologics Inc.